- Epredia and NovaScan Announce Intent to Enter U.S. Distribution Agreement for ... - Le Lézard
- Vesica Health Announces Launch of AssureMDx Test to Improve Bladder Cancer Detection
- Angle signs AstraZeneca deal to develop prostate cancer assay
- Earnings call: Twist Bioscience sees robust revenue growth in Q2 - Investing.com Canada
- Angle signs AstraZeneca deal to develop prostate cancer assay - Medical Device Network
- [Latest] Global Cancer Cachexia Market Size/Share Worth USD 5.1 Billion by 2033 at a 5.1% CAGR
- Cancer Biomarkers Market Trends and Global Forecasts, 2024-2035 - GlobeNewswire
- CORRECT: Angle shares up on assay development deal with AstraZeneca
- Companion Diagnostics Technologies and Global Markets Report 2023-2024 and 2028 ...
- Karius Raises $100M Series C | citybiz
- ANGLE inks £550000 deal with AstraZeneca for prostate cancer detection, shares jump
- [Latest] Global Cancer Cachexia Market Size/Share - One News Page
- FTSE opens in the green on Friday ahead of US jobs report - Shares Magazine
- Angle PLC Announces New Commercial Agreement with Large Pharma - Morningstar
- ANGLE teams up with AstraZeneca on a second assay | AIM:AGL, OTCQX:ANPCY
Be the first to comment